John Markels - Dec 8, 2022 Form 4 Insider Report for Arcturus Therapeutics Holdings Inc. (ARCT)

Role
Director
Signature
/s/ Grant Levine, as attorney-in-fact for Dr. John Markels
Stock symbol
ARCT
Transactions as of
Dec 8, 2022
Transactions value $
$0
Form type
4
Date filed
12/13/2022, 03:10 PM
Previous filing
Jun 6, 2022
Next filing
Jun 5, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARCT Stock option (right to buy) Award $0 +20K $0.00 20K Dec 8, 2022 Common Stock 20K $18.04 Direct F1
transaction ARCT Stock option (right to buy) Award $0 +6.99K $0.00 6.99K Dec 8, 2022 Common Stock 6.99K $18.04 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares underlying the option vest monthly over a two year period from the date of grant. This represents the initial grant to the Reporting Person as a member of the Board of Directors (the "Board").
F2 Shares underlying the option vest monthly over a one year period from the date of grant. This represents the annual grant to the Reporting Person as a member of the Board, prorated based on the date the Reporting Person was appointed to the Board, representing an estimated six months of service.